Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Update of what the Cannabix Breathalyzer will look like and what it will do.
http://www.cannabixtechnologies.com/media-relations.html
Apparently a prototype is being readied for February 2015 release....these guys are way ahead of the herd in this field.
http://www.ibtimes.com/driving-while-high-marijuana-breathalyzer-horizon-police-struggle-stop-stoned-drivers-1734400
In addition WSU is working on technology that has been proven too not work with miniaturization of a mass spectometer. Take a look at this miniature masss spec comoany...they tried to test trace levels of thc with their mass spec and could not do it.
http://908devices.com
I think BLO is still dealing with the $.05 placement becoming free trading..once that clears up and the prototype is revealed. this will shoot up
I suggest people phone WSU if they are concerned that WSU is ahead of BLOZF...
Professor Herbert Hill at Herbert H. Hill (509) 335-5648. I was told by him that the media have misreported his story. They are just starting to look into this business
BLOZF is on the cusp of having a product ready
Also, this bodes well, in that naturally there will be competitors and the fact that others companies are chasing BLOZF is verification that BLOZF has a head start on a product that will have a huge huge market.
Washington State University-Academic not commercial
I contacted HHerbert Hill at WSU and he stated that his group is looking at assigning a grad student to look into breath detection/....The articles in the paper are misleading in that they make it appear as if WSU is a commercial outfit ready to market a breathalyzer to the market. WSU is an academic outfit and they have never develped any commercial products are only beginning to look at the possibility of a breath testing.
Do your own DD before panicking. I believe BLO is the only company that is in the advanced stages of having a product ready for the market.
Dr. Hebert Hill of the WSU can be found here:
http://hill.chem.wsu.edu
He has over 200 peer reviewed scientific publications; several patents related to IMS; and two edited books on trace detection and chromatographic detectors. At Washington State University he has served as director of the Office of Grants and Research Development, Associate Dean of the Graduate School, and is currently a Regents Professor in the Chemistry Department. Dr. Hill is a founder of the International Ion Mobility Society
Tommorow's presentation:
Yahoo to Participate at the Credit Suisse Technology Conference
Business Wire Yahoo! Inc.
November 25, 2014 12:00 PM
????
SUNNYVALE, Calif.--(BUSINESS WIRE)--
Yahoo! Inc. (YHOO) CFO Ken Goldman will participate in a question-and-answer session at the Credit Suisse Technology Conference in Scottsdale.
The session is scheduled to begin on Tuesday, December 2, 2014, at 9:00 a.m. PT / 12:00 p.m. ET.
A live webcast of the session will be available on the Investor Relations website at http://yhoo.client.shareholder.com/events.cfm?CalendarID=5.
About Yahoo
Yahoo is focused on making the world's daily habits inspiring and entertaining. By creating highly personalized experiences for our users, we keep people connected to what matters most to them, across devices and around the world. In turn, we create value for advertisers by connecting them with the audiences that build their businesses. Yahoo is headquartered in Sunnyvale, California, and has offices located throughout the Americas, Asia Pacific (APAC) and the Europe, Middle East and Africa (EMEA) regions. For more information, visit the pressroom (pressroom.yahoo.net) or the Company's blog (yahoo.tumblr.com).
Yahoo is the trademark and/or registered trademark of Yahoo! Inc.
All other names are trademarks and/or registered trademarks of their respective owners.
Contact:
Yahoo! Inc.
Media Relations:
Sarah Meron, 408-349-4040
friday could be huge....I ee threer spiel being created without tax impliaacationd out of yahoo bring announced se per the rtile,
http://www.forbes.com/sites/ericjackson/2014/11/17/why-yahoo-can-reach-80-per-share-in-the-next-year/
the only approvals required in the US is the National Highway Safety Administration....no FDA approval required.
Click here to view larger image
Click here to view larger image
Approvals
NHTSA (U.S. DOT)
Datasheets
Alco-Sensor VXL
Alco-Sensor VXL with printer
Alco-Sensor VXL RBT Version
Alco-Sensor VXL @Point of Arrest
Alco-Sensor® VXL
E-mail this product to a friend
Description
Specifications
Images/Videos
Printers
Introduction:
The Alco-Sensor VXL (ASVXL) is an advanced, handheld, microprocessor driven, breath alcohol testing instrument. The ASVXL provides a simple, economical method of determining a subject’s breath alcohol concentration with evidential grade accuracy. Additionally, the instrument offers the ability to perform rapid screening and passive testing of subjects. It can also be used to perform a headspace analysis of a sample over a liquid.
The instrument’s design offers great flexibility. The Alco-Sensor VXL can be used in a stand-alone mode and it can be interfaced with a serial printer to provide a printed record of a test. Alternatively, the ASVXL can interface through a docking station or wireless connection with multiple peripherals, including keyboards, printers, magnetic card readers, bar code readers and computers. A wide range of options are available to configure the instrument to your program needs.
Unique Features:
The Alco-Sensor VXL was designed with operator safety in mind. Unlike other instruments available, the ASVXL's symmetric design with a rear facing display allows the operator to remain in control of the subject, view the instrument display, monitor the surrounding environment and divert the subject’s breath away from the operator during the sample collection process.
The instrument is quickly prepared for testing with use of Intoximeters easily attached mouthpieces, passive cups and drink sniffers (depending on the testing protocol selected.)
The ASVXL also offers advantages in low light operations such as an illuminated mouthpiece guide, a lever & snap mouthpiece insertion, side-viewable LED indicator, and multi-color back lit display messaging to warn of important test conditions.
http://www.wxyz.com/news/comapny-developing-marijuana-breathalyzer
"they will make a billion dollars of this"
Another post of early alcohol breathalyzer
http://www.nytimes.com/2002/08/17/us/robert-f-borkenstein-89-inventor-of-the-breathalyzer.htmlRobert F. Borkenstein, who revolutionized enforcement of drunken driving laws by inventing the Breathalyzer to measure alcohol in the blood, died last Saturday at his home in Bloomington, Ind. He was 89.
The Breathalyzer is a portable device that can determine whether the person being tested is legally drunk. It measures the proportion of alcohol vapors in exhaled air, a proportion that reflects the content of alcohol in the blood.
Before widespread use of the device, police officers investigating an accident or noticing a weaving car looked for symptoms like a flushed face, slurred speech and bloodshot eyes. If the suspect then went to sleep in the police station, they might have sufficient basis for charges.
Getting a conviction was harder still. Defense lawyers might say the suspect had been staggering because of the long hours he worked, and bring in friends to say he had had no more than two beers. The defendant might maintain that his eyes had been red as a result of allergies.
Read more at http://www.stockhouse.com/companies/bullboard/c.blo/west-point-resources-inc#H7wOi0c7mRqHoBpT.99
Great read and input into how we are at a cusp in MJ
http://paleofuture.gizmodo.com/drunk-driving-and-the-pre-history-of-breathalyzers-1474504117
Before the advent of the car, being drunk was a relatively minor nuisance for society at large. Most of the time, imbibing too much of your preferred poison did little to put strangers in harm's way. The automobile, with its incredible speed and considerable weight, changed all that. Today, roughly 30% of America's traffic fatalities involve a drunk driver. Back in the 1950s and '60s, that percentage was closer to 50%.
Those staggering numbers kicked off the pursuit of a simple device, one that could determine any defendant's guilt with the push of a button. That was the hope (and fear) of people who were fighting over the development of the very first breathalyzer technologies.
The first serious scientific work on mechanizing the determination of whether someone was driving drunk took place in the 1920s. A doctor and researcher in Los Angeles by the name of Dr. Emil Bogen conducted a landmark study in 1927 on how to scientifically determine inebriation. By this time it was fairly well-established that testing blood gave you a solid idea of how drunk a person might be. But by testing urine, blood, and breath, Bogen found that the latter could indeed function as a reliable estimator for blood alcohol content (BAC).
Dr. Bogen's breath test used a large football bladder that contained sulphuric acid and potassium dichromate. A patient would breathe into it, and as the chemicals in the football bladder changed from yellow to various shades of blue and green, they were compared to tubes of the same chemicals in which different amounts of alcohol had been added. Effective, but not the most practical for a traffic stop.
Another person whose early work would contribute to the birth of the breathalyzer was W.D. McNally in Chicago. The picture above ran in the November 1927 issue of Science and Inventionmagazine showing off McNally's "breath analyzer."
McNally was a chemist whose early breathalizer-like device used the same principles as Dr. Bogen; blowing into the tube of the device would cause the chemicals to turn a greenish hue if there was any alcohol present. Photos of McNally's device ran in popular tech magazines, promising that soon, there would be a reliable and objective way to determine if someone had indeed been driving drunk.
Read more at http://www.stockhouse.com/companies/bullboard/c.blo/west-point-resources-inc#Qu2IPFW33YI2hHIs.99
October 9, 2014
Tekmira to Present HBV Pre-Clinical Data at Meeting of the Oligonucleotide Therapeutics Society
VANCOUVER, British Columbia, Oct. 9, 2014 (GLOBE NEWSWIRE) -- Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics, today announced that Dr. Ian MacLachlan, Tekmira's Executive Vice President and Chief Technical Officer, will present preclinical data for TKM-HBV, the Company's product candidate targeting hepatitis B virus, at the 10th Annual Meeting of the Oligonucleotide Therapeutics Society. The presentation will take place on Wednesday, October 15, 2014 at 12 pm (PT) / 3 pm (ET) in San Diego at The Hilton San Diego Resort and Spa.
Presentation Information
On October 15, the Company will be issuing a press release highlighting key components of the presentation. The presentation will also be available after the podium event on Tekmira's website in the events section at www.tekmira.com.
About Tekmira
Tekmira Pharmaceuticals Corporation is a biopharmaceutical company focused on advancing novel RNAi therapeutics and providing its leading lipid nanoparticle (LNP) delivery technology to pharmaceutical partners. Tekmira has been working in the field of nucleic acid delivery for over a decade and has broad intellectual property covering LNPs. Further information about Tekmira can be found at www.tekmira.com. Tekmira is based in Vancouver, B.C. Canada.
CONTACT: Investors
Julie P. Rezler
Director, Investor Relations
Phone: 604-419-3200
Email: jrezler@tekmira.com
Media
Please direct all media
CNNN has been nothing but Ebola North American spread coverage Monday morning...
I think that (hope) that TKMR hits well over $25 next week
Chimerex is bid around $23 today....$10 lower then yesterday. Hopefully the dismal failure of their drug, makes TKMR the choice as it worked on a patient who recovered. Pre Market bids on TKMR are looking like we will see a strong day in TKMR while Chimerex tumbles further
Doctors have been using several experimental drugs and treatments to supplement the usual care in the cases of five people who have come to the United States after being infected in Africa.
The two current patients, Thomas Eric Duncan in Dallas and Ashoka Mukpo in Omaha, are being treated with brincidofovir, an oral antiviral.
The medication was developed by Chimerix Inc. of Durham, N.C., and designed to fight cytomegalovirus and other viruses, according to the company’s website.
Two medical missionaries, Dr. Kent Brantly and Nancy Writebol, received another experimental drug, ZMapp, produced by Mapp Biopharmaceutical Inc. of San Diego.
ZMapp is described as a mix of antibodies that were created to target the Ebola virus. Officials say there are no more doses of this treatment, though there are efforts to produce more.
Dr. Rick Sacra was treated in Nebraska with another experimental drug, TKM-Ebola, from Tekmira Pharmaceuticals of Canada.
It works by blocking genes that help the Ebola virus reproduce and spread. It is also said to be in limited supply.
cComments
@Skip Adam What's that got to do with the price of tea in China?
AFFABLEMAN
AT 6:46 PM OCTOBER 07, 2014
ADD A COMMENTSEE ALL COMMENTS
3
Sacra also received blood transfusions from an infected patient who survived Ebola.
This type of blood transfusion is designed to jump-start the patient’s immunity, according to Dr. Phil Smith, director of the Nebraska hospital's biocontainment unit.
Looks like Chimerex dose failed and their patient died... the go to guys now are TKMR...I say we see $28 tomorrow.
http://www.ibtimes.com/experimental-ebola-drug-maker-chimerix-stock-falls-after-dallas-ebola-patient-dies-1700818
Looks like a strong open for TKMR today at $24 pre market.
I don't think anything has changed in TKMR products...they are really really bad at PR and Chimera is really really good the last week.
I see TKMR going back to the $28-30 range.
Did anyone listen to the BIO conference on their website...the CEO totally talks like a doctor and has no promotional ability
TKMR also has FDDA APPPROVAL---today overruling is just scared investors running for the exits...it should recover to the $26 rnage
MARKETS More: Ebola Virus Biotech
Ebola Drug Firm Tekmira Is Surging Again
Colorized scanning electron micrograph of filamentous Ebola virus particles (green) attached and budding from a chronically infected VERO E6 cell (orange) (25,000x magnification).
Shares of Tekmira Pharmaceuticals were up more than 14% on Monday after the company announced that it reached a "regulatory framework" with the FDA for using its TKM-Ebola treatment to treat Ebola.
In a press release, Tekmira said:
Tekmira Pharmaceuticals Corporation, a leading developer of RNA interference (RNAi) therapeutics, today announced that the FDA has authorized Tekmira to provide TKM-Ebola for treatment
Read more: http://www.businessinsider.com/tekmira-reaches-fda-agreement-on-ebola-treatment-2014-9#ixzz3FNFyTfYb
Does anyone know if all the IPO stock has been sold and that there is no loose stock coming up for trading any time soon? Please advise
Apple going to china is fixed into the stock. It was the same she the IPHONE % went for salie there..th stock fizzled…
There is nothing exciting to be announced ny Appple…even their earnings have been forward guided…its linger under $98
There is a gap from (8$ close on Friday to the open today. The gap must be closed and its looking like its getting close to be being closed. Maybe it will bottom at $98 today. I would nt rush to buy...there is no urgent good news due out on this stock until at a month away...so far everything has been turning to sit for them
Insiders know its a top that if why they are selling into the BDNING phone, IS)* that doesn't work and European banks that want the laundered money back.
Every life has its ups and downs...Appls had a great up month now its time for the down.
Apple set to open below 99.50 this morning.we will test the under $95 level before week is thru.
Cream always rises to the top,,but once in a while the best of us walk into a pile of shit. Tim Cook has stored that up last week and it continues today
Pay seems tone stepping in shit at every turn since last week. BENDGATE IOS* and NOW the EURPOEAN TAX troubles.
You can't tell me that investors will be blind t all this crap happening and will not put their money at better valuationfs for short terms. Even is the next earning are good (and they will not inlude the current iPhone sales)..nothing will hold up the hype of ver $100.
I suggest we will test the low $.90...this stock had a great run to the IPHONE6 release but since then they has shat the bed
Will Icahn come back
Not With a Bang, but a Whimper: Icahn Leaves Yahoo Board (Plus His Entire Letter)
OCTOBER 23, 2009 AT 3:00 PM PT
Share on Facebook
inShare
Share
Print
icahnhasyurboard
Carl Icahn, the activist billionaire investor who made such a noisy fuss in his quest to force management and other changes at Yahoo, is taking a much quieter leave from the Internet giant’s board.
He apparently has told the Yahoo (YHOO) board that “there was not a need at this time for an activist investor” and that he has a lot of other companies he invests in to focus on.
That’s true, of course, given a spate of troubled investments that Icahn is dealing with.
But here’s BoomTown’s quickie analysis: Yahoo CEO Carol Bartz completely ignores him.
In fact, Bartz often has gone out of her way to take little gibes at Icahn since she got the top job in January, whether it’s to say he called her too much or that he could try to fire her if he did not like the job she was doing.
For example, she just dissed him publicly in a piece in Forbes, tossing off a saucy insult:
“Icahn is just another shareholder. What’s he going to do, fire me?”
But Yahoo was cordial to Icahn as he departed, even if a lot of people at the company who had battled him were likely thinking: “Don’t let the door hit you on the way out!”
“Carl has been an important member of our Board and has helped us through some significant transitions,” said the Yahoo statement. We are all grateful for his active role shaping the future of Yahoo! and wish him well in all his endeavors.”
Icahn in the second board member to leave under Bartz’s tenure.
Frontier Communications (FTR) CEO Maggie Wilderotter announced in late September that she was stepping down from the board by year’s end.
It will be interesting to see who–if anyone–will comes on board as a director and, of course, if there are more departures. After the departures of Wilderotter and Icahn, there will be 10 directors.
(Here is BoomTown’s No. 1 pick still in that regard.)
In taking his leave, Icahn praised the recent search and online advertising deal Bartz struck with Microsoft (MSFT), noting that it will “provide great long-term benefits, the potential of which many still do not understand.”
lolcat-failure
Nice final toss to try to spike the stock, Carl! But the MicroHoo deal, which has yet to be approved by regulators, was likely cold comfort for him.
Icahn sank large sums of money in Yahoo with hopes of a big score via the hostile takeover attempt by Microsoft at a price upward of $30 a share.
After that deal tanked, Icahn has seen his stake decline in value.
He sold 16 percent of his Yahoo shares in late August, leaving him with a 4.5 percent stake, or about 63 million shares.
It is also not clear today if Icahn intends to unload more of the stock.
In 2008, he couldn’t buy enough, scooping up the stock at much higher prices.
After mounting a proxy fight–including the lobbing of a series of poison-pen letters–against former CEO and co-founder Jerry Yang and his management team, Icahn got board seats for himself and two others (John Chapple and Frank Biondi) in July of 2008.
As Digital Daily’s John Paczkowski put it perfectly then:
“Having so persuasively argued that Carl Icahn is a doddering Luddite with no articulated plan for Yahoo other than the company’s sale to Microsoft, Yahoo has taken the logical next step and appointed the activist shareholder to its board of directors.”
At the time of the fighting, Yahoo used a quote from Icahn to insult him: “It’s hard to understand these technology companies.”
In a way, that is a pretty accurate description of Icahn’s long wrangle with the Silicon Valley icon.
And, while some might not agree with my take, this is the way the Yahoo world ends for Icahn: Full of sound and fury, signifying nothing.
Here is Icahn’s entire letter to the Yahoo board:
To the Yahoo! Board of Directors:
I am hereby tendering my resignation as a director of Yahoo! to take effect immediately.
When I joined the Board, the company was in a state of turmoil. In the period since then, we have all worke
CARL ICAHN to come into the fray.
knowing how he loves deals that are undervalued by the billions,,,I would not be surprised to see his name come up in the Yahoo talks next week. We knows the company and has owned a big pivotal position in it.
ALso, I wouldn't be surprised if Softbank or Alibaba made a bid for Yahoo. Sfotbnak would end up owning 50% of the stock in Ailbaba if they merged with Yahoo and they would get Yahoo Japan and North America for free.
This is on fire sale. I also think more analysts will drum the play up next week. Jim Kramer has already talked $48.
Find out if (BABA) is in Cramer's Portfolio.
NEW YORK (TheStreet) -- Ahead of the launch of trading in Alibaba (BABA_) shares later today, research firm Piper Jaffray believes that much of the easy gains in Yahoo's (YHOO_) stock have already been realized. The focus will now be on how the shares of Alibaba that Yahoo does not sell today will be taxed, the firm stated.
WHAT'S NEW: The stock of Chinese e-commerce behemoth Alibaba, in which Yahoo holds a roughly 22% stake, was priced at $68 per share and are due to start trading later today on the New York Stock Exchange. The IPO priced slightly above the previously anticipated range of $60-$66, as reported on September 5.
ANALYST OPINION: The "easy money" from Yahoo's stock, which has risen 11% over the last month, "is off the table," Piper Jaffray analyst Gene Munster wrote in a note to investors today. Investors' focus will now be on the tax treatment of Yahoo's remaining shares in Alibaba that it does not sell soon after the onset of trading in the name, Munster believes. Yahoo will be able to avoid paying "essentially all tax" on this second tranche of about 400M shares, but the company may take several quarters in order to decide how to do so, the analyst believes. There is a 75% chance that the U.S. company will pay no tax on these shares, and a 25% chance that it will pay the full 38% tax rate, wrote Munster. He decided to value the second tranche of Yahoo's shares in Alibaba based on a 10% tax rate and a value of $81 per share. As a result, the analyst raised his price target on Yahoo to $48 from $44 and kept a Buy rating on the stock. Meanwhile, Cantor analyst Youssef Squali agreed that tax efficiency would be the key issue for Yahoo going forward. He raised his price target on the U.S. company to $43 from $39, but added that the stock could be worth $53-$58 if Yahoo is able to sell its second tranche of shares in Alibaba in a tax efficient manner. Squali kept a Buy rating on Yahoo.
The starboard letter was a move to put short sellers on notice..I think the message was delivered and there is a lot of short that needs to be covered. A responses from Mayer and snorters covering will see us in the $45-47 range
Its a great investment and trading at a huge discount to NET ASSET value...with Softbank and Alibaba who can make excellent partners for a merger with Yahoo
APPPLE MOMENTUM IS OVER ND THERE ARE TO MANY COMPLICATIONS WITH THE IPHONE
Apple reached their high when they announced the new phone. now that there are major problems with it...we will test the low $.90's.
Great ad by Samsung
samsung ad
Samsung's latest ad skewers Apple for the iPhone 6 Plus' bending problem. Samsungsamsung ad
Samsung's latest ad skewers Apple for the iPhone 6 Plus' bending problem. Samsung
http://www.ibtimes.com/new-samsung-ad-capitalizes-apples-iphone-6-plus-bending-problem-1694861
I think that as of Thursday BABA will have call options and be sortable. That should relieve pressure on SOFTBANK and YAHOO
I say BAB goes to $110 Monday. The Chinese and Japanese will be first day to the market and any flippers from the $68 are out on the 266M shares that traded Friday/. Too bad it opened on a Friday..or maybe its a good thing..the Asian will scramble to get into this Monday.
I think we will also see YHPP move up allot it makes so much sense for BAB to sue their stock price to buy Yahoo now and get the billions in cash, Yhoo North America and Yhoo Japan
IT would make sense for BABA to take over Yahoo,,,they get billions in cash, yahoo US , Yahoo Japan and they can cancel the 16% that yahoo owns
Lots of shorting on Yhoo today..but when they have to cover it will be above $45.
Also it makes so much sense for BABA to takeover Yahoo
What are peoples thoughts that EBAY will stumble once Alibaba comes out of the gate with $20B in hand and ready to launch in North America?
Time to sell some puts on b=ebay?
BABA unlike facebiik Twitter and GoPro will not be limited to high net worth investors from North America. Alibaba will will be a WORLD phenomena and people from the globe will invest in it.
Also, with $20M cash on hand, BABA will give ebay and Amazon a real run for their money.
Smart retail investors would be well advised to:
Buy call options on Yahoo as they own 23% of BABA
Sell Put Optons on ebay and Amazn as investors will pul out of those to get into the least play BABA
That is my strategy and i plan to hold onto to this until the Oct3 call expiry.
I don't think Yahoo is going down during this and Ebay and Amazon will suffer from the strength of BABA
Can anyone dicer what the difference is between the SFTBY and SFTBF. One trades at $82 and the other is an ADR that trades at $42. What does the ADR mean?
Sorry for ignorance but please post if you know the answer
Cannabix Technologies Update.
This stock is trading leader on the Canadian Exchange and just got its symbol in the US BLOZF,
Listen to this update:
http://www.pinnacledigest.com/podcast/interview-kal-mahli-president-cannabix-technologies
New interview with Cannabix President:
http://www.pinnacledigest.com/podcast/interview-kal-mahli-president-cannabix-technologies